Methoxyphenamine Other names: 2-methoxy-N-methylamphetamine (OMMA)

Chemical formula: C₁₁H₁₇NO  Molecular mass: 179.259 g/mol 

Active ingredient description

Methoxyphenamine is a beta adrenergic receptor agonist nd is used as a bronchodilator to treat asthma, chronic obstructive pulmonary disease (COPD) and postinfectious cough.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
R03CB02 Methoxyphenamine R Respiratory system → R03 Drugs for obstructive airway diseases → R03C Adrenergics for systemic use → R03CB Non-selective beta-adrenoreceptor agonists
Discover more medicines within R03CB02

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 93-30-1
DrugBank Drug: DB13624
RxNorm Ingredient: 29704
SNOMED-CT Concept: 69351002
Methoxyphenamine (substance)
UNII Identifier: J3Z5SRI26Z
METHOXYPHENAMINE

Medicines

Methoxyphenamine is an active ingredient of these brands:

Hong Kong (HK)

  • (combination) ASMETON as METHOXYPHENAMINE HYDROCHLORIDE
  • (combination) CHUCO as METHOXYPHENAMINE HYDROCHLORIDE
  • (combination) METHON-S as METHOXYPHENAMINE HYDROCHLORIDE
  • (combination) YESON CHILDREN as METHOXYPHENAMINE HYDROCHLORIDE
  • (combination) ZIBON CHILDREN as METHOXYPHENAMINE HYDROCHLORIDE

Ireland (IE)

Malta (MT)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.